Roche to buy remaining stake in Foundation Medicine for $2.4bn

Image: Roche and Foundation Medicine sign definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology. Photo: courtesy of F. Hoffmann-La Roche Ltd.